SCHEDULE 13G/A

CASI PHARMACEUTICALS INC

Ordinary Shares, par value $0.0001 · CUSIP: G1933S101

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Foresite Capital Fund VI, L.P.

  Shares: 787,121.00 · Class: 5.1%

• Foresite Capital Management VI, LLC

  Shares: 787,121.00 · Class: 5.1%

• James Tananbaum

  Shares: 787,121.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.